Amishi Y. Shah, MD Assistant Professor Genitourinary Medical Oncology MD Anderson Cancer Center Discusses Immunotherapy Moving To Frontline. At Kidney…
Browsing: Kidney
Amishi Y. Shah, MD Assistant Professor Genitourinary Medical Oncology MD Anderson Cancer Center Discusses Gut Microbiome Upcoming Research. At Kidney…
Pavlos Msaouel, MD, PhD Assistant Professor Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center discusses Analyzing Biological…
Pavlos Msaouel, MD, PhD Assistant Professor Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center discusses Kidney Cancer…
Pavlos Msaouel, MD, PhD Assistant Professor Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center discusses Rare Kidney…
Brian Shuch, MD Associate Professor of Urology at UCLA Discusses the Optimal Approach To Small Renal Mass. At Kidney Cancer…
Pavlos Msaouel, MD, PhD Assistant Professor Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center discusses Renal Medullary…
Pavlos Msaouel, MD, PhD Assistant Professor Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center discusses Immunotherapy In…
VITALY MARGULIS MD ASSOCIATE PROFESSOR UROLOGIC ONCOLOGY discusses Why Use Systemic Therapy Before Surgery?. At Kidney Cancer Association National Patient…
VITALY MARGULIS MD ASSOCIATE PROFESSOR UROLOGIC ONCOLOGY discusses Radiotherapy In Kidney Cancer. At Kidney Cancer Association National Patient and Caregiver…
VITALY MARGULIS MD ASSOCIATE PROFESSOR UROLOGIC ONCOLOGY discusses EA8143 PROSPER RCC: Adjuvant Therapy with a Twist. At Kidney Cancer Association…
Chung-Han Lee, MD/PhD Memorial Sloan Kettering Cancer Center Discusses Objective Response Rate, Best Indicator? At Kidney Cancer Association National Patient…
Chung-Han Lee, MD/PhD Memorial Sloan Kettering Cancer Center Discusses Combinations in Kidney Cancer, Who Benefits? At Kidney Cancer Association National…
Chung-Han Lee, MD/PhD Memorial Sloan Kettering Cancer Center Discusses Combination, TKI, Immunotherapy Efficacy. At Kidney Cancer Association National Patient and…
Jose A. Karam, MD, FACS Associate Professor Departments of Urology and Translational Molecular Pathology Discusses Von Hippel-Lindau Disease. At Kidney…
Jose A. Karam, MD, FACS Associate Professor Departments of Urology and Translational Molecular Pathology Discusses Localized Recurrence Is Rare In…
Michael R. Harrison, MD Associate Professor of Medicine Duke University Medical Center Duke Cancer Institute discusses Sequencing Immunotherapies In Kidney…
Michael R. Harrison, MD Associate Professor of Medicine Duke University Medical Center Duke Cancer Institute discusses Ipilimumab & Nivolumab Combo.…
Michael R. Harrison, MD Associate Professor of Medicine Duke University Medical Center Duke Cancer Institute discusses First Line Therapy In…
Michael R. Harrison, MD Associate Professor of Medicine Duke University Medical Center Duke Cancer Institute discusses Combo Avelumab & Axitinib.…
Michael R. Harrison, MD Associate Professor of Medicine Duke University Medical Center Duke Cancer Institute discusses Combinations In Anti VEGF…
Naomi B Haas MD Director of Kidney and Prostate Cancer Clinical Programs Abramson Cancer Center discusses VEGF Inhibitors In Adjuvant…
Naomi B Haas MD Director of Kidney and Prostate Cancer Clinical Programs Abramson Cancer Center discusses The Allure To The…
Naomi B Haas MD Director of Kidney and Prostate Cancer Clinical Programs Abramson Cancer Center discusses ASSURE, S-TRAC, ATLAS, &…
Susan Demo, Ph.D Calithera Biosciences discusses Only 3% Of Cancer Patients Participate In Clinical Trials at Kidney Cancer Association National…
Mayer Fishman, MD PhD Dept. of GU Oncology Moffitt Cancer Center Dept. of Oncologic Sciences, USF Morsani College of Medicine…
Susan Demo, Ph.D Calithera Biosciences Discusses the Best Way For A Patient To Find A Clinical Trial. At Kidney Cancer…
Matt Campbell MD, MS Assistant Professor Department of Genitourinary Medical Oncology UT MD Anderson Cancer Center Discusses What Does PDL…
Matt Campbell MD, MS Assistant Professor Department of Genitourinary Medical Oncology UT MD Anderson Cancer Center Discusses When Should A…
Philippe E. Spiess, M.D., MS, FRCS(C), FACS Senior Member, Department of GU Oncology Senior Member, Department of Tumor Biology Assistant…
Eric A. Singer, MD, MA, FACS Assistant Professor of Surgery and Radiology Director, Kidney Cancer Program Rutgers Cancer Institute of…
Eric A. Singer, MD, MA, FACS Assistant Professor of Surgery and Radiology Director, Kidney Cancer Program Rutgers Cancer Institute of…
Eric A. Singer, MD, MA, FACS Assistant Professor of Surgery and Radiology Director, Kidney Cancer Program Rutgers Cancer Institute of…
Eric A. Singer, MD, MA, FACS Assistant Professor of Surgery and Radiology Director, Kidney Cancer Program Rutgers Cancer Institute of…
Brian Shuch, MD Associate Professor of Urology at UCLA Discusses the Risk Of New Tumor Developing at Kidney Cancer Association…
Brian Shuch, MD Associate Professor of Urology at UCLA Discusses the Treatment Of The Incidental Renal Mass at Kidney Cancer…
E Jason Abel, MD FACS University of Wisconsin School of Medicine and Public Health discusses Surgery in kidney cancer at…
E Jason Abel, MD FACS University of Wisconsin School of Medicine and Public Health Discusses the Higher Risk Of Occurrence…
E Jason Abel, MD FACS University of Wisconsin School of Medicine and Public Health discusses the Complex Surgery Locally Advanced…
Matt Campbell MD, MS Assistant Professor Department of Genitourinary Medical Oncology UT MD Anderson Cancer Center asks the question why…
Mayer Fishman, MD PhD Dept. of GU Oncology Moffitt Cancer Center Dept. of Oncologic Sciences, USF Morsani College of Medicine…
Chung-Han (Joe) Lee, MD/PhD Memorial Sloan Kettering Cancer Center discusses Novel combinational therapies: Is the increased toxicity worth the possibility…
Pavlos Msaouel, MD, PhD Assistant Professor Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center discusses Systemic treatment…
Amishi Y. Shah, MD Assistant Professor Genitourinary Medical Oncology MD Anderson Cancer Center discusses the best agents for second line…
Michael R. Harrison, MD Associate Professor of Medicine Duke University Medical Center Duke Cancer Institute discusses What is the best…
VITALY MARGULIS MD ASSOCIATE PROFESSOR UROLOGIC ONCOLOGY of UT Southwestern discusses NEOADJUVANT THERAPY PRIOR TO SURGERY at the Kidney Cancer…
Eric A. Singer, MD, MA, FACS Assistant Professor of Surgery and Radiology Director, Kidney Cancer Program Rutgers Cancer Institute of…
Susan Demo, Ph.D of Calithera discusses Why should I participate in a clinical trial?? Whats in it for me? at…
Jose A. Karam, MD, FACS Associate Professor Departments of Urology and Translational Molecular Pathology at MD Anderson discusses What are…
Philippe E. Spiess, M.D., MS, FRCS(C), FACS Senior Member, Department of GU Oncology Senior Member, Department of Tumor Biology Assistant…